Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Mas-Coma S, 2005. Epidemiology of fascioliasis in human endemic areas. J Helminthol 79 :207–216.
-
2
Mas-Coma S, Bargues MD, Valero MA, 2005. Fascioliasis and other plant-borne trematode zoonoses. Int J Parasitol 35 :1255–1278.
-
3
Chen MG, Mott KE, 1990. Progress in assessment of morbidity due to Fasciola hepatica infections: a review of recent literature. Trop Dis Bull 87 :R1–R38.
-
4
Mas-Coma S, Esteban JG, Bargues MD, 1999. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 77 :340–346.
-
5
Mas-Coma S, Bargues MD, Valero MA, 2007. Plantborne trematode zoonoses: fascioliasis and fasciolopsiasis. Murrel D, Fried B, eds. World Class Parasites: Food-Borne Parasites, Fish and Plant-Borne Parasites. Volume 11. New York: Springer Verlag, 293–334.
-
6
Hopkins DR, 1992. Homing in on helminths. Am J Trop Med Hyg 46 :626–634.
-
7
Mas-Coma S, 2004. Human fascioliasis. Cotruvo JA, Dufour A, Rees G, Bartram J, Carr R, Cliver DO, Craun GF, Rayer R, Gannon VPJ, eds. Waterborne Zoonoses: Identification, Causes and Control. London: IWA Publishing, 305–322.
-
8
WHO, 1995. Control of foodborne trematode infections. WHO Tech Rep Ser 849 :1–157.
-
9
Valero MA, Navarro M, García-Bodelón MA, Marcilla A, Morales M, Hernández JL, Mengual P, Mas-Coma S, 2006. High risk of bacterobilia in advanced experimental chronic fasciolosis. Acta Trop 100 :17–23.
-
10
Valero MA, Gironès N, García-Bodelón MA, Periago MV, Chico-Calero I, Khoubbane M, Fresno M, Mas-Coma S, 2008. Anaemia in advanced chronic fasciolosis. Acta Trop 108 :35–43.
-
11
Espino AM, Duménigo BE, 2003. Fasciola hepatica. Miliotis MD, Bier JW, eds. International Handbook of Foodborne Pathogens. New York, Basel: Marcel Dekker, Inc., 539–562.
-
12
Garcia LS, 2007. Liver and lung trematodes. García LS, ed. Diagnostic Medical Parasitology. Fifth edition. Washington, DC: ASM Press, 423–444.
-
13
Lim JH, Mairiang E, Ahn GH, 2008. Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis. Abdom Imaging 33 :157–165.
-
14
Mas-Coma S, Bargues MD, Esteban JG, 1999. Human fascioliasis. Dalton JP, ed. Fascioliasis. Wallingford, Oxon, UK: CABI Publishing, 411–434.
-
15
Marcos LA, Tagle M, Terashima A, Bussalleu A, Ramírez C, Carrasco C, Valdez L, Huerta Mercado J, Freedman DO, Vinetz JM, Gotuzzo E, 2008. Natural history, clinicoradiologic correlates, and response to triclabendazol in acute massive fasciolosis. Am J Trop Med Hyg 78 :222–227.
-
16
MacLean JD, Cross J, Mahanty S, 2006. Liver, lung and intestinal fluke infections. Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases, Principles, Pathogens and Practice. Second edition. Philadelphia, PA: Elsevier Churchill Living-stone, 1349–1369.
-
17
Maeda T, Yamada H, Akao N, Iga M, Endo T, Koibuchi T, Nakamura T, Odawara T, Iwamoto A, Fujii T, 2008. Unusual radiological findings of Fasciola hepatica infection with huge cystic and multilocular lesions. Intern Med 47 :449–452.
-
18
Marcos LA, Maco V, Terashima A, Gotuzzo E, 2002. Clinical characteristics of chronic infection by Fasciola hepatica in children. Rev Gastroenterol Peru 22 :228–233.
-
19
Abdel-Rahman S, O’Reilly KL, Malone JB, 1998. Evaluation of a diagnostic monoclonal antibody-based capture enzyme-linked immunosorbent assay for detection of a 26–28 kd Fasciola hepatica coproantigen in cattle. Am J Vet Res 59 :533–537.
-
20
Espino AM, Finlay CM, 1994. Sandwich enzyme-linked immunosorbent assay for detection of excretory secretory antigens in humans with fascioliasis. J Clin Microbiol 32 :190–193.
-
21
Mezo M, Gonzalez-Warleta M, Carro C, Ubeira FM, 2004. An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3). J Parasitol 90 :845–852.
-
22
Valero MA, Ubeira FM, Khoubbane M, Artigas P, Muiño L, Mezo M, Perez-Crespo I, Periago MV, Mas-Coma S, 2009. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and Fasciola gigantica.Vet Parasitol 159 :77–81.
-
23
Charlier J, De Meulemeester L, Claerebout E, Williams D, Vercruysse J, 2008. Qualitative and quantitative evaluation of coprological and serological techniques for the diagnosis of fascioliasis in cattle. Vet Parasitol 153 :44–51.
-
24
Nichols G, Thom BT, 1984. Screening for Criptosporidium in stools. Lancet 1 :734–735.
-
25
Hillyer GV, 1999. Immunodiagnosis of human and animal fascioliasis. Dalton JP, ed. Fascioliasis. Wallingford, Oxon, UK: CABI Publishing, 435–447.
-
26
Dumenigo BE, Espino AM, Finlay CM, 1996. Detection of Fasciola hepatica antigen in cattle faeces by a monoclonal antibody-based sandwich immunoassay. Res Vet Sci 60 :278–279.
-
27
Estuningsih SE, Widjayanti S, Adiwinata G, Piedrafita D, 2004. Detection of coproantigens by sandwich ELISA in sheep experimentally infected with Fasciola gigantica.Trop Biomed 21 :51–56.
-
28
Mezo M, González-Warleta M, Castro-Hermida JA, Ubeira FM, 2008. Evaluation of the flukicide treatment policy in dairy cattle from Galicia (NW Spain). Vet Parasitol 157 :235–243.
-
29
Ashrafi K, Valero MA, Panova M, Periago MV, Massoud J, Mas-Coma S, 2006. Phenotypic analysis of adults of Fasciola hepatica, Fasciola gigantica and intermediate forms from the endemic region of Gilan, Iran. Parasitol Int 55 :249–260.
-
30
Le TH, De NV, Agatsuma F, Thi Nguyen TG, Nguyen QD, McManus DP, Blair D, 2008. Human fascioliasis and the presence of hybrid/introgressed forms of Fasciola hepatica and Fasciola gigantica in Vietnam. Int J Parasitol 38 :725–730.
-
31
Periago MV, Valero MA, El Sayed M, Asharafi K, El Wakeel A, Mohamed MY, Desquesnes M, Curtale F, Mas-Coma S, 2008. First phenotypic description of Fasciola hepatica/Fasciola gigantica intermediate forms from the human endemic area of the Nile Delta, Egypt. Infect Genet Evol 8 :51–58.
-
32
Montresor A, Crompton DWT, Bundy DAP, Hall A, Savioli L, 1998. Guidelines for the Evaluation of Soil-Transmitted Helminthiasis and Schistosomiasis at Community Level. A Guide for Managers of Control Programmes. Geneva, Switzerland: World Health Organization. WHO/CTD/SIP/98.1.
-
33
WHO, 2007. Report of the WHO Informal Meeting on use of triclabendazole in fascioliasis control. Geneva, Switzerland: World Health Organization. WHO/CDS/NTD/PCT/2007.1.
-
34
Borgsteede FHM, Taylor SM, Gaasenbeek CPH, Couper A, Cromie L, 2008. The efficacy of an ivermectin/closantel injection against experimentally induced infections and field infections with gastrointestinal nematodes and liver fluke in cattle. Vet Parasitol 155 :235–241.
-
35
Valero MA, De Renzi M, Panova M, Garcia-Bodelon MA, Periago MV, Ordoñez D, Mas-Coma S, 2006. Crowding effect on adult growth, pre-patent period and egg shedding of Fasciola hepatica.Parasitology 133 :453–463.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 23 | 23 | 8 |
| Full Text Views | 313 | 96 | 1 |
| PDF Downloads | 98 | 35 | 0 |
MM3-ELISA Detection of Fasciola hepatica Coproantigens in Preserved Human Stool Samples
Florencio M. Ubeira
Florencio M. Ubeira
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by Florencio M. Ubeira in
Current site
Google Scholar
PubMed
Search for other papers by Florencio M. Ubeira in
Current site
Google Scholar
PubMed
Laura Muiño
Laura Muiño
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by Laura Muiño in
Current site
Google Scholar
PubMed
Search for other papers by Laura Muiño in
Current site
Google Scholar
PubMed
M. Adela Valero
M. Adela Valero
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by M. Adela Valero in
Current site
Google Scholar
PubMed
Search for other papers by M. Adela Valero in
Current site
Google Scholar
PubMed
M. Victoria Periago
M. Victoria Periago
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by M. Victoria Periago in
Current site
Google Scholar
PubMed
Search for other papers by M. Victoria Periago in
Current site
Google Scholar
PubMed
Ignacio Pérez-Crespo
Ignacio Pérez-Crespo
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by Ignacio Pérez-Crespo in
Current site
Google Scholar
PubMed
Search for other papers by Ignacio Pérez-Crespo in
Current site
Google Scholar
PubMed
Mercedes Mezo
Mercedes Mezo
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by Mercedes Mezo in
Current site
Google Scholar
PubMed
Search for other papers by Mercedes Mezo in
Current site
Google Scholar
PubMed
Marta González-Warleta
Marta González-Warleta
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by Marta González-Warleta in
Current site
Google Scholar
PubMed
Search for other papers by Marta González-Warleta in
Current site
Google Scholar
PubMed
Fernanda Romarís
Fernanda Romarís
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by Fernanda Romarís in
Current site
Google Scholar
PubMed
Search for other papers by Fernanda Romarís in
Current site
Google Scholar
PubMed
Esperanza Paniagua
Esperanza Paniagua
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by Esperanza Paniagua in
Current site
Google Scholar
PubMed
Search for other papers by Esperanza Paniagua in
Current site
Google Scholar
PubMed
Sandra Cortizo
Sandra Cortizo
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by Sandra Cortizo in
Current site
Google Scholar
PubMed
Search for other papers by Sandra Cortizo in
Current site
Google Scholar
PubMed
José Llovo
José Llovo
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by José Llovo in
Current site
Google Scholar
PubMed
Search for other papers by José Llovo in
Current site
Google Scholar
PubMed
Santiago Más-Coma
Santiago Más-Coma
Laboratorio de Parasitología, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Departamento de Parasitología, Facultad de Farmacia, Universidad de Valencia, Valencia, Spain; Centro de Investigaciones Agrarias, Mabegondo, A Coruña, Spain; Servicio de Microbiología, Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Search for other papers by Santiago Más-Coma in
Current site
Google Scholar
PubMed
Search for other papers by Santiago Más-Coma in
Current site
Google Scholar
PubMed
In this study, we evaluate the MM3-COPRO method for detection of Fasciola coproantigens in human fecal samples, and the usefulness of a new preservative/diluent, CoproGuard, developed for preservation of Fasciola coproantigens. The MM3-COPRO assay was evaluated with 213 samples from healthy patients, 30 Fasciola positive fecal samples (according to the Kato-Katz method), and 83 samples from patients with other parasitic infections. All Fasciola positive specimens were detected with the MM3-COPRO assay (100% sensitivity) and there was no cross-reactivity with other common parasites present in the clinical specimens analyzed (100% specificity). The use of CoproGuard enhanced coproantigen extraction without affecting the detection limit of the assay, and the antigenicity of Fasciola coproantigens in fecal samples stored at 37°C was retained throughout the entire observation period (120 days). We concluded that the MM3-COPRO ELISA combined with the use of CoproGuard may be a very useful tool for the diagnosis of human fascioliasis.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Mas-Coma S, 2005. Epidemiology of fascioliasis in human endemic areas. J Helminthol 79 :207–216.
-
2
Mas-Coma S, Bargues MD, Valero MA, 2005. Fascioliasis and other plant-borne trematode zoonoses. Int J Parasitol 35 :1255–1278.
-
3
Chen MG, Mott KE, 1990. Progress in assessment of morbidity due to Fasciola hepatica infections: a review of recent literature. Trop Dis Bull 87 :R1–R38.
-
4
Mas-Coma S, Esteban JG, Bargues MD, 1999. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 77 :340–346.
-
5
Mas-Coma S, Bargues MD, Valero MA, 2007. Plantborne trematode zoonoses: fascioliasis and fasciolopsiasis. Murrel D, Fried B, eds. World Class Parasites: Food-Borne Parasites, Fish and Plant-Borne Parasites. Volume 11. New York: Springer Verlag, 293–334.
-
6
Hopkins DR, 1992. Homing in on helminths. Am J Trop Med Hyg 46 :626–634.
-
7
Mas-Coma S, 2004. Human fascioliasis. Cotruvo JA, Dufour A, Rees G, Bartram J, Carr R, Cliver DO, Craun GF, Rayer R, Gannon VPJ, eds. Waterborne Zoonoses: Identification, Causes and Control. London: IWA Publishing, 305–322.
-
8
WHO, 1995. Control of foodborne trematode infections. WHO Tech Rep Ser 849 :1–157.
-
9
Valero MA, Navarro M, García-Bodelón MA, Marcilla A, Morales M, Hernández JL, Mengual P, Mas-Coma S, 2006. High risk of bacterobilia in advanced experimental chronic fasciolosis. Acta Trop 100 :17–23.
-
10
Valero MA, Gironès N, García-Bodelón MA, Periago MV, Chico-Calero I, Khoubbane M, Fresno M, Mas-Coma S, 2008. Anaemia in advanced chronic fasciolosis. Acta Trop 108 :35–43.
-
11
Espino AM, Duménigo BE, 2003. Fasciola hepatica. Miliotis MD, Bier JW, eds. International Handbook of Foodborne Pathogens. New York, Basel: Marcel Dekker, Inc., 539–562.
-
12
Garcia LS, 2007. Liver and lung trematodes. García LS, ed. Diagnostic Medical Parasitology. Fifth edition. Washington, DC: ASM Press, 423–444.
-
13
Lim JH, Mairiang E, Ahn GH, 2008. Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis. Abdom Imaging 33 :157–165.
-
14
Mas-Coma S, Bargues MD, Esteban JG, 1999. Human fascioliasis. Dalton JP, ed. Fascioliasis. Wallingford, Oxon, UK: CABI Publishing, 411–434.
-
15
Marcos LA, Tagle M, Terashima A, Bussalleu A, Ramírez C, Carrasco C, Valdez L, Huerta Mercado J, Freedman DO, Vinetz JM, Gotuzzo E, 2008. Natural history, clinicoradiologic correlates, and response to triclabendazol in acute massive fasciolosis. Am J Trop Med Hyg 78 :222–227.
-
16
MacLean JD, Cross J, Mahanty S, 2006. Liver, lung and intestinal fluke infections. Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases, Principles, Pathogens and Practice. Second edition. Philadelphia, PA: Elsevier Churchill Living-stone, 1349–1369.
-
17
Maeda T, Yamada H, Akao N, Iga M, Endo T, Koibuchi T, Nakamura T, Odawara T, Iwamoto A, Fujii T, 2008. Unusual radiological findings of Fasciola hepatica infection with huge cystic and multilocular lesions. Intern Med 47 :449–452.
-
18
Marcos LA, Maco V, Terashima A, Gotuzzo E, 2002. Clinical characteristics of chronic infection by Fasciola hepatica in children. Rev Gastroenterol Peru 22 :228–233.
-
19
Abdel-Rahman S, O’Reilly KL, Malone JB, 1998. Evaluation of a diagnostic monoclonal antibody-based capture enzyme-linked immunosorbent assay for detection of a 26–28 kd Fasciola hepatica coproantigen in cattle. Am J Vet Res 59 :533–537.
-
20
Espino AM, Finlay CM, 1994. Sandwich enzyme-linked immunosorbent assay for detection of excretory secretory antigens in humans with fascioliasis. J Clin Microbiol 32 :190–193.
-
21
Mezo M, Gonzalez-Warleta M, Carro C, Ubeira FM, 2004. An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3). J Parasitol 90 :845–852.
-
22
Valero MA, Ubeira FM, Khoubbane M, Artigas P, Muiño L, Mezo M, Perez-Crespo I, Periago MV, Mas-Coma S, 2009. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and Fasciola gigantica.Vet Parasitol 159 :77–81.
-
23
Charlier J, De Meulemeester L, Claerebout E, Williams D, Vercruysse J, 2008. Qualitative and quantitative evaluation of coprological and serological techniques for the diagnosis of fascioliasis in cattle. Vet Parasitol 153 :44–51.
-
24
Nichols G, Thom BT, 1984. Screening for Criptosporidium in stools. Lancet 1 :734–735.
-
25
Hillyer GV, 1999. Immunodiagnosis of human and animal fascioliasis. Dalton JP, ed. Fascioliasis. Wallingford, Oxon, UK: CABI Publishing, 435–447.
-
26
Dumenigo BE, Espino AM, Finlay CM, 1996. Detection of Fasciola hepatica antigen in cattle faeces by a monoclonal antibody-based sandwich immunoassay. Res Vet Sci 60 :278–279.
-
27
Estuningsih SE, Widjayanti S, Adiwinata G, Piedrafita D, 2004. Detection of coproantigens by sandwich ELISA in sheep experimentally infected with Fasciola gigantica.Trop Biomed 21 :51–56.
-
28
Mezo M, González-Warleta M, Castro-Hermida JA, Ubeira FM, 2008. Evaluation of the flukicide treatment policy in dairy cattle from Galicia (NW Spain). Vet Parasitol 157 :235–243.
-
29
Ashrafi K, Valero MA, Panova M, Periago MV, Massoud J, Mas-Coma S, 2006. Phenotypic analysis of adults of Fasciola hepatica, Fasciola gigantica and intermediate forms from the endemic region of Gilan, Iran. Parasitol Int 55 :249–260.
-
30
Le TH, De NV, Agatsuma F, Thi Nguyen TG, Nguyen QD, McManus DP, Blair D, 2008. Human fascioliasis and the presence of hybrid/introgressed forms of Fasciola hepatica and Fasciola gigantica in Vietnam. Int J Parasitol 38 :725–730.
-
31
Periago MV, Valero MA, El Sayed M, Asharafi K, El Wakeel A, Mohamed MY, Desquesnes M, Curtale F, Mas-Coma S, 2008. First phenotypic description of Fasciola hepatica/Fasciola gigantica intermediate forms from the human endemic area of the Nile Delta, Egypt. Infect Genet Evol 8 :51–58.
-
32
Montresor A, Crompton DWT, Bundy DAP, Hall A, Savioli L, 1998. Guidelines for the Evaluation of Soil-Transmitted Helminthiasis and Schistosomiasis at Community Level. A Guide for Managers of Control Programmes. Geneva, Switzerland: World Health Organization. WHO/CTD/SIP/98.1.
-
33
WHO, 2007. Report of the WHO Informal Meeting on use of triclabendazole in fascioliasis control. Geneva, Switzerland: World Health Organization. WHO/CDS/NTD/PCT/2007.1.
-
34
Borgsteede FHM, Taylor SM, Gaasenbeek CPH, Couper A, Cromie L, 2008. The efficacy of an ivermectin/closantel injection against experimentally induced infections and field infections with gastrointestinal nematodes and liver fluke in cattle. Vet Parasitol 155 :235–241.
-
35
Valero MA, De Renzi M, Panova M, Garcia-Bodelon MA, Periago MV, Ordoñez D, Mas-Coma S, 2006. Crowding effect on adult growth, pre-patent period and egg shedding of Fasciola hepatica.Parasitology 133 :453–463.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 23 | 23 | 8 |
| Full Text Views | 313 | 96 | 1 |
| PDF Downloads | 98 | 35 | 0 |